Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Washington D.C. DC, McLean VA, Largo MD,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Washington D.C. DC, McLean VA, Largo MD,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase2, Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
for
ALS
Location: Washington D.C. DC, Philadelphia PA, Hamilton, London,
Sponsor: Amylyx Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06665165
Phase1, Recruiting
Pediatric Boot Camp Program
for
Type 1 Diabetes, Children, Only
Location: Washington DC
Sponsor: Georgetown University
Sex: All
Age: 11 - 18
Code: NCT05066893
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Hinge vs CCK Implants
for
Revision Arthroplasty, Knee
Location: Washington D.C. DC, Olney MD
Sponsor: Medstar Health Research Institute
Sex: All
Age: 18 - 70+
Code: NCT07818343
Recruiting
New
Hard Cervical Collar Use Following Posterior Cervical Fusion
Location: Washington DC, Falls Church VA, Baltimore MD,
Sponsor: Transplant Genomics, Inc.
Sex: All
Age: 18+
Code: NCT04491552
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Washington D.C. DC, Fairfax VA, East Brunswick NJ,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase2, Recruiting
Evaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic Amputations
for
Surgical Wound, Wound Heal, Amputation
Location: Washington DC
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT03250442
Recruiting
A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI)
for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University
Sex: Female
Age: 50 - 70+
Code: NCT02457117
Recruiting
Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
for
Catheter-related Infections
Location: Washington DC, Salem VA, Newark NJ, Greenville NC,
Sponsor: Leonard-Meron Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT02901717
Phase3, Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Washington D.C. DC, Williamsburg VA, Philadelphia PA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase2, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Washington D.C. DC, Hanover MD, Annapolis MD,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase3, Recruiting
Vibroacoustic Study of Lung Development in Newborn Infants
for
Prematurity, Premature Birth, Premature Lungs,
Location: Washington DC
Sponsor: Level 42 AI, Inc.
Sex: All
Age: 0 - 2
Code: NCT05827250
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma